Rice Hall James & Associates’s Abiomed Inc ABMD Stock Holding History

Rice Hall James & Associates’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,790	Closed	-$446K	–	317
2015 Q2	$446K	Sell	6,790 -5,635	-45%	-$374K	0.03%	273
2015 Q1	$889K	Buy	12,425 +323	+3%	+$17.5K	0.05%	253
2014 Q4	$461K	Buy	12,102 +169	+1%	+$5.33K	0.03%	276
2014 Q3	$296K	Buy	11,933 +147	+1%	+$3.72K	0.02%	275
2014 Q2	$296K	Buy	11,786 +166	+1%	+$3.86K	0.02%	281
2014 Q1	$303K	Buy	11,620 +475	+4%	+$13.1K	0.02%	282
2013 Q4	$298K	Buy	+11,145	New	+$275K	0.02%	281

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rice Hall James & Associates's ABMD Position: Q3 2015 in Review

Rice Hall James & Associates sold out of Abiomed Inc (ABMD) in Q3 2015, closing a stake of 6,790 shares — an estimated $446K sold.

Rice Hall James & Associates first reported a position in ABMD in Q4 2013 and held it in 7 quarters. The position peaked at $889K in Q1 2015. 243 funds tracked by Wall St. Rank hold ABMD as of Q3 2015.

Rice Hall James & Associates reported no remaining Abiomed Inc position as of Q3 2015 after selling out during the quarter.
Rice Hall James & Associates sold 6,790 Abiomed Inc shares in Q3 2015, an estimated $446K.
Rice Hall James & Associates first reported a position in Abiomed Inc in Q4 2013 and held it in 7 quarters.
Rice Hall James & Associates's Abiomed Inc position peaked at $889K in Q1 2015.
243 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2015.

Based on Rice Hall James & Associates's 13F filing for Q3 2015, filed 30 Oct 2015.